SIK2 promotes ovarian cancer cell motility and metastasis by phosphorylating MYLK.
Shi X, Yu X, Wang J, Bian S, Li Q, Fu F, Zou X, Zhang L, Bast RC Jr, Lu Z, Guo L, Chen Y, Zhou J.
Shi X, et al. Among authors: zhang l.
Mol Oncol. 2022 Jul;16(13):2558-2574. doi: 10.1002/1878-0261.13208. Epub 2022 Mar 25.
Mol Oncol. 2022.
PMID: 35278271
Free PMC article.